Skip navigation

Strategies and Tools to Mitigate Risk and Drive Proactive Monitoring Practices

February 27-28, 2018
  • Philadelphia, PA

Now in its sixth year, CBI’s Compliance Monitoring 2018 serves as the only life sciences event focused exclusively on building and boosting monitoring and testing programs. This must-attend conference empowers compliance professionals to utilize data and monitoring resources to align with the business.

Key Reasons to Attend:

  • Hear the latest on what government attorneys have to say about
    current trends in compliance monitoring activities
  • Understand the small to mid-sized organization’s resource
    constraints — Taking a strategic and risk-based approach to
    monitoring and auditing activities
  • Examine compliance monitoring processes around increased
    patient engagement, specialty pharmacy interactions and
    reimbursement support programs
  • Deploy data analytics and predictive modeling to enhance auditing,
    speed retraining and to quickly address potential noncompliance
  • Consider the key steps to achieve standardized data collection,
    ensure data quality and enable ease of data analysis
  • Determine best practices for continuing monitoring efforts post CIA

Previous Attendee Acclaim:

Compliance Monitoring is a great way to learn best practices and network. I’ll be back next year

Global Publication Planning Monitor, Bristol-Myers Squibb

This is a great opportunity to learn tangible monitoring strategies no matter what phase your monitoring program is in.

Director, Oversight and Monitoring, Johnson & Johnson

A great way to learn more about monitoring and to
meet monitoring peers in other organizations.

Lead analyst, MD Monitoring, Johnson & Johnson

Compliance Monitoring 2018

Strategies and Tools to Mitigate Risk and Drive Proactive Monitoring Practices

Now in its sixth year, CBI’s Compliance Monitoring 2018 serves as the only life sciences event focused exclusively on building and boosting monitoring and testing programs. This must-attend conference empowers compliance professionals to utilize data and monitoring resources to align with the business.

Key Reasons to Attend:

  • Hear the latest on what government attorneys have to say about
    current trends in compliance monitoring activities
  • Understand the small to mid-sized organization’s resource
    constraints — Taking a strategic and risk-based approach to
    monitoring and auditing activities
  • Examine compliance monitoring processes around increased
    patient engagement, specialty pharmacy interactions and
    reimbursement support programs
  • Deploy data analytics and predictive modeling to enhance auditing,
    speed retraining and to quickly address potential noncompliance
  • Consider the key steps to achieve standardized data collection,
    ensure data quality and enable ease of data analysis
  • Determine best practices for continuing monitoring efforts post CIA

Previous Attendee Acclaim:

Compliance Monitoring is a great way to learn best practices and network. I’ll be back next year

Global Publication Planning Monitor, Bristol-Myers Squibb

This is a great opportunity to learn tangible monitoring strategies no matter what phase your monitoring program is in.

Director, Oversight and Monitoring, Johnson & Johnson

A great way to learn more about monitoring and to
meet monitoring peers in other organizations.

Lead analyst, MD Monitoring, Johnson & Johnson